David Fenyö

NYU Langone Health — United States

Chemistry · Physical Sciences

76h-index28.5kcitations459works6.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Proteomics Techniques and Applications(93), Mass Spectrometry Techniques and Applications(67), Cancer Genomics and Diagnostics(54), Chromosomal and Genetic Variations(41), RNA modifications and cancer(36)

Publications454 total

Genome writing and Targeted Delivery of the <i>NKX6-3/ANK1</i> gene cluster and its Type 2 Diabetes GWAS Variants to Human iPSCs
2026Open Access
BDIViz: An Interactive Visualization System for Biomedical Schema Matching with LLM-Powered Validation
IEEE Transactions on Visualization and Computer Graphics·2025· 1 cited
SLFN11 counteracts the RFWD3-PRIMPOL DNA damage tolerance axis to restrain gapped DNA synthesis in response to replication stress
Nature Communications·2025Open Access
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Cell·2025· 33 citedOpen Access
Pan-cancer analysis reveals context-dependent roles of LINE-1 ORF1p in immune regulation and copy number alterations
2025Open Access
Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneity
Clinical and Translational Medicine·2025· 1 citedOpen Access
Optimizing end of life care in elderly ovarian cancer patients: What can we do better?
Gynecologic Oncology·2025
Non-segmented unsupervised learning of multispectral whole slide images for robust analysis of tissue repair and regeneration
2025Open Access
Decoding the gene regulatory landscape through multimodal learning of protein-DNA interactions
2025Open Access
Integrative analysis of lung adenocarcinoma across diverse ethnicities and exposures
Cancer Cell·2025· 2 citedOpen Access
SimSpace: a comprehensive in-silico spatial omics data simulation and modeling framework
2025Open Access
Correction: B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry
Frontiers in Immunology·2025Open Access
A shotgun approach for highly multiplexed mammalian metabolic engineering
2025Open Access
Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies
Cancer·2025· 5 citedOpen Access
B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with multiple sclerosis of African ancestry
Frontiers in Immunology·2025Open Access
Melanoma Proteomics Unveiled: Harmonizing Diverse Data Sets for Biomarker Discovery and Clinical Insights via MEL-PLOT
Journal of Proteome Research·2025· 3 citedOpen Access
Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center
Journal of Proteomics·2025Open Access
Precision proteogenomics reveals pan-cancer impact of germline variants
Cell·2025· 4 citedOpen Access
African-American MS Patients with and Without Early B-cell Repletion After Anti-CD20 Monoclonal Infusion Therapy Have Similarly Low Levels of Disease Activity (P10-1.009)
Neurology·2025
B cell-extrinsic and intrinsic factors linked to early immune repletion after anti-CD20 therapy in patients with Multiple Sclerosis of African Ancestry
2025Open Access
page 1 of 23Next →

Frequent Co-authors

Henry Rodriguez(19), D.R. Mani(18), Mehdi Mesri(17), Bing Zhang(16), Li Ding(16), Kelly V. Ruggles(14), Amanda G. Paulovich(14), Steven A. Carr(14), Christopher R. Kinsinger(13), Tara Hiltke(13), Karl R. Clauser(12), Pei Wang(12), Song Cao(12), Karsten Krug(12), Mathangi Thiagarajan(12), Antonio Colaprico(12), Michael A. Gillette(11), Samuel Payne(11), Emily S. Boja(11), Karin Rodland(11)